Skip to main content
Inventage Lab Inc. logo

Inventage Lab Inc. — Investor Relations & Filings

Ticker · 389470 ISIN · KR7389470006 KO Professional, scientific and technical activities
Open in API
Filings indexed 195 across all filing types
Latest filing 2022-12-27 Director's Dealing
Country KR South Korea
Listing KO 389470

About Inventage Lab Inc.

https://www.inventagelab.com/m/en/

Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose insider transactions, such as the exercise of stock options by a director. This falls under the 'Director's Dealing' category as it reports personal share transactions by a company executive.
2022-12-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (directors/executives) due to the exercise of stock options. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-12-27 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Inventage Lab regarding the exercise of stock options (주식매수선택권 행사). It details the number of shares exercised, the exercise price, the individuals involved (directors and employees), and the impact on total shares. This type of disclosure regarding the issuance of new shares resulting from stock option exercises falls under the category of 'Share Issue/Capital Change'.
2022-12-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action related to shareholder rights. Given it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2022-12-14 Korean
투자판단관련주요경영사항(알코올 의존성 및 opioid 의존성 치료제(IVL3004) 호주 임상 제1상 시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Inventage Lab regarding a clinical trial application (Phase 1 for IVL3004). It follows the standard format for a 'Major Management Matter' (주요경영사항) disclosure in the Korean market, which is a regulatory announcement. Since it does not fit into specific categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2022-12-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. This type of filing is used to report significant changes in share ownership (crossing thresholds) by major shareholders or institutional investors. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2022-12-05 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.